Previous 10 | Next 10 |
2023-03-28 14:37:12 ET Extending a three-day winning streak, shares of Pyxis Oncology ( PYXS ), a micro-cap biotech backed by Pfizer ( PFE ), added ~42% on Tuesday to reach the highest level since April 2022 on above-average volume. About 35.6M Pyxis ( PYXS ) shares ...
2023-03-28 13:10:56 ET Gainers: Biomea Fusion ( BMEA ) +73% . Oscar Health ( OSCR ) +72% . Viking Therapeutics ( VKTX ) +63% . Pyxis Oncology ( PYXS ) +46% . Bird Global ( BRDS ) +44% . NaaS Technology ( NAAS ) +26% ....
2023-03-28 06:00:00 ET 3 Beginner Penny Stocks Trading Mistakes to Avoid Right Now Penny stocks have long been a popular choice for beginner traders looking to enter the world of investing. Known for their low prices, typically below $5 per share, these small-cap stocks offer an attract...
2023-03-27 17:05:01 ET Gainers: Near Intelligence ( NIR ) +12% . Lyft ( LYFT ) +5% . Madrigal Pharmaceuticals ( MDGL ) +4% . Purple Innovation ( PRPL ) +4% . Pyxis Oncology ( PYXS ) +3% . Losers: Freightcar America ( RA...
2023-03-27 13:06:40 ET Gainers: WiSA Technologies ( WISA ) +93% . First Citizens BancShares ( FCNCA ) +50% . Alimera Sciences ( ALIM ) +38% . Cimpress ( CMPR ) +30% . Gorilla Technology Group ( GRRR ) +25% . CBL International...
2023-03-27 10:47:00 ET Gainers: Pyxis Oncology ( PYXS ) +25% . Delcath Systems DCTH +23% . Jounce Therapeutics ( JNCE ) +23% . Alimera Sciences ( ALIM ) +22% . Coeptis Therapeutics ( COEP ) +21% . Losers: Unity Biotechnology ...
2023-03-27 08:52:49 ET First Citizens BancShares ( FCNCA ) +39% deal for First Citizens to buy Silicon Valley Bank. First Republic Bank ( FRC ) +24% inks deal for First Citizens to buy Silicon Valley Bank. Baudax ( BXRX ) +26% Announces Posi...
2023-03-27 07:32:43 ET Summary PYXS has initiated dosing with PYX-201 in a phase 1 study, with preliminary results due in early 2024. PYXS expects to initiate dosing in a phase 1 study of PYX-106 in Q2'23, which could add additional readouts to the 2024 calendar. PYXS trades v...
2023-03-24 08:11:09 ET Dermata Therapeutics ( DRMA ) +23% . Pyxis Oncology ( PYXS ) +13% . NEXGEL ( NXGL ) +10% . ADMA Biologics ( ADMA ) +8% Q4 earnings call release Heron Therapeutics ( HRTX ) +7% Q4 earnings call release K...
2023-03-23 17:01:12 ET Gainers: Pyxis Oncology ( PYXS ) +15% . CRISPR Therapeutics ( CRSP ) +11% . ADMA Biologics ( ADMA ) +6% . Harrow Health ( HROW ) +4% . Solid Power ( SLDP ) +5% . Losers: Scholastic ( SCHL ) -1...
News, Short Squeeze, Breakout and More Instantly...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effecti...
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer PYX-106 Phase 1 trial clinical readout on track for 2H 2024 Expected cash runway i...